ENT Powered Instrument Market Size, Share, & COVID-19 Impact Analysis - Global - 2023-2029 - MedCore - Includes: Capital Equipment and Disposables

ENT Powered Instrument Market Size, Share, & COVID-19 Impact Analysis - Global - 2023-2029 - MedCore - Includes: Capital Equipment and Disposables

The global market for ENT powered instruments was valued at $881.6 million in 2022 and is anticipated to grow at a CAGR of 3.3% during the forecast period to reach $1.1 billion. The complete report suite on the global market for ENT powered instruments includes an analysis of the capital equipment and disposable markets.

MARKET DATA INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends
Procedure Numbers
COVID-19 Impact Analysis
Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

GLOBAL ENT POWERED INSTRUMENT MARKET INSIGHTS

The rise in otolaryngologic procedures worldwide is one of the primary factors driving the ENT powered instrument market. With increasing access to affordable healthcare and advanced technologies, more people are able to undergo ENT procedures, leading to an upsurge in demand for powered instruments. Additionally, the growth of healthcare services in developing economies is expected to further propel market growth.

GLOBAL ENT POWERED INSTRUMENT MARKET SHARE INSIGHTS

The Global ENT powered instrument market was led by Medtronic, Stryker, and Olympus.
Medtronic was the market leader in the ENT powered instrument market, with a dominant position in the power shaver segment, holding a majority share. The company's success is largely attributed to its two most popular products, the Straightshot® M4 and M5 Microdebriders, for which it coined the term microdebrider. Medtronic also holds a leading position in the power drill market, with its portfolio of otologic drills, including Indigo, Visao®, and Midas Rex®.

MARKET SEGMENTATION SUMMARY

ENT Powered Instrument Market – MedCore – Includes:
Subsegments of capital equipment and disposable markets.

RESEARCH SCOPE SUMMARY

Regions : North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast Period: 2023-2029
Historical Data: 2019-2022
Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices
Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.